Filing Details

Accession Number:
0001615774-18-001587
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-05 08:56:05
Reporting Period:
2018-03-02
Accepted Time:
2018-03-05 08:56:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1314052 Anavex Life Sciences Corp. AVXL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1196573 U Christopher Missling 51 W 52Nd Street, 7Th Floor
New York NY 10019-6163
Director, President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-03-02 1,650 $2.41 1,013,900 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2018.